There is a hole in Korea’s Covid-19 response system.The government emphasizes the need to return to the general healthcare system but provides few backup measures or support, putting more strain on the medical field. Under the Covid-19 response system from which “even the government wants to escape,
The court has postponed the initial ruling over the civil lawsuit between Medytox and Daewoong Pharmaceutical over the origin of the latter's botulinum toxin strains to next year.The suit is regarding Medytox filing a civil lawsuit against Daewoong, claiming that the latter stole the BTX strain thro
GC Biopharma said on Monday that its I.V.-Globulin SN inj. 10% (ingredient: human immunoglobulin-G) for treating autoimmune encephalitis patients demonstrated safety and efficacy in prospective clinical trials.Autoimmune encephalitis is a disease that causes neurological deficits through autoimmune
PharmAbcine, a Korean antibody treatment developer, said it would collaborate with the U.S. Merck (known as MSD outside North America) to develop PMC-309, a “VISTA (V-domain Ig suppressor of T cell activation) antibody, for a phase 1 study.PMC-309 will be tested for its safety and efficacy in advanc
Noul said it signed the memorandum of understanding (MoU) with Ghana Infectious Disease Center (GIDC) to cooperate on strengthening onsite malaria diagnostic capability in Ghana.According to the company, Ghana’s population of about 30 million is exposed to the risk of malaria.“There are more than fi
Orum Therapeutics said on Monday that its acute myeloid (AML) drug candidate, ORM-6151, demonstrated superior safety and efficacy compared to competing drugs in preclinical trials, at the American Society of Hematology (ASH) in New Orleans, the U.S.ORM-6151 is the second candidate material to utiliz
Korean dental clinics, equipped with the superior technology and low-cost services, are gearing up to attract foreign patients amid the eased Covid-19 pandemic.Especially after Korea lifted all the quarantine restrictions for travelers entering Korea, the Korea Health Industry Development Institute
In early 2018, AstraZeneca proved Tagrisso (osimertinib)’s efficacy in improving the progression-free survival (PFS) of EGFE-mutation non-small cell lung cancer as its primary treatment based on a global phase 3 clinical trial of FLAURA study.Tagrisso also demonstrated its benefits in overall surviv
SD Biosensor said it delayed the acquisition date of Meridian Bioscience, a U.S. diagnostics company.According to a public filing on Monday, SD Biosensor said it will revise the expected date of acquiring stocks and investment securities of Meridian Bioscience from Jan. 7 to Jan. 31, 2023."This is a
Conflict over Humasis’s management control is deepening between CEO Cha Jeong-hak and the company’s minority shareholders.However, the company’s share prices have sharply risen ahead of the extraordinary shareholders meeting scheduled for February to discuss the participation in management by the un
Samsung Biologics said on Sunday that it has been included in the Dow Jones Sustainability Index (DSJI), a global ESG representative evaluation index, for the second consecutive year. Also, it ranked second in the life service science industry.The DJSI selects the top 10 percent of globally listed c
The government has relaxed regulations on the prescription for antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), allowing doctors other than psychiatrists to prescribe the drug multiple times.The Ministry of Health and Welfare announced on Nov. 30 that it would change the ant
Competition in the reusable and electronic mask market is heating up as two companies, LG Electronics and Dyson unveiled their reusable air purifying masks in a respective public announcement on Thursday.LG’s electronic air purifying mask called, LG PuriCare Mask, was first launched in Hong Kong las
Adolescents aged 12-17 will be able to receive Pfizer’s bivalent Covid-19 vaccine that has increased efficacy against the Omicron variant from next week.According to the Central Disaster and Safety Countermeasure Headquarters, the target of the winter booster vaccination will be expanded from the cu
Novartis said iptacopan, a targeted factor B inhibitor, proved effective in complement-inhibitor-naïve (including anti-C5 therapies) adults with paroxysmal nocturnal hemoglobinuria (PNH) in a phase 3 study.The Switzerland-based company announced on Thursday that iptacopan met the primary endpoint of
SK Biopharmaceuticals said that Angelini Pharma, its EU partner, has won sales approval for cenobamate, an epilepsy drug, in France.The company initially launched cenobamate, under the product name Ontozry, in the EU market after obtaining sales approval from the European Commission in March last ye
Many might be surprised to learn that companies like Uber were once small start-ups. Similarly, in the medical space, technology-driven healthcare solutions have seen rapid growth with the explosion of artificial intelligence (AI) boosting the success of Korean companies like VUNO, Lunit, and 3billi
HanAll Biopharma said it would receive a $10 million milestone payment from Roivant Sciences, a Switzerland-based company, for the technology transfer regarding an investigational autoimmune disease treatment HL161 (ingredient: batoclimab).In a regulatory filing on Thursday, HanAll Biopharma said it
A civic group strongly criticized the government and its party, after an amendment to the National Health Insurance Act failed to pass the National Assembly Health and Welfare Committee’s subcommittee due to partisan disagreement Thursday.The amendment bill contained the expansion of state funding f
The Korea Disease Control and Prevention Agency (KDCA) commissioner Peck Kyong-ran suggested the timing for adjusting the obligation to wear indoor masks will come as early as January next year.“We are reviewing a policy of adjusting the provisions of administrative orders and fines for compliance w